Kingfa India Board Approves Q1 FY27 Results, Recommends Final Dividend of ₹20/share
Kingfa India's Board approved Q1 FY27 unaudited standalone results. A final dividend of ₹20 per share for FY26 was recommended, subject to member approval. Record date set for September 21, 2026. Key appointments include Wang Dazhong as CMD, Sethuraman Shanmugasundaram as COO, and Xie Dongming as CFO.
The recommendation of a final dividend and significant management changes have a moderate impact on the company's governance and shareholder returns.
The company reported financial results and recommended a final dividend, which are positive developments for shareholders. The board meeting also addressed key management appointments, indicating continued operational and strategic focus.
Kingfa Science & Technology (India) Limited announced the outcome of its Board Meeting held on August 14, 2026. The Board approved the Unaudited Standalone Financial Results for the quarter ended June 30, 2026, which had been reviewed by the Audit Committee on August 13, 2026.
Additionally, the Board recommended a Final Dividend of ₹20 per equity share of ₹10 each for the financial year ended March 31, 2026. This recommendation is subject to the approval of the company's members at the upcoming Annual General Meeting. The Record Date for determining eligible shareholders for this dividend has been fixed as September 21, 2026.
The meeting, which commenced at 10:30 AM and concluded at 7:10 PM, also saw several key management changes. Mr. Wang Dazhong was appointed as Additional Director and Chairman & Managing Director, succeeding Mr. Bo Jingen, who resigned from these positions effective August 14, 2026. Mr. Sethuraman Shanmugasundaram was appointed as Additional Director and Whole-time Director, designated as Chief Operating Officer, effective August 15, 2026. Mr. Doraiswami Balaji resigned from his position as Whole-time Director, designated as Executive Director, effective September 30, 2026.
Further, Mr. Xie Dongming was appointed as the Chief Financial Officer (Key Managerial Personnel) effective August 15, 2026, replacing Mr. Chen Xiaogiong, who resigned on August 14, 2026. Ms. Apurva Pradeep Joshi was appointed as an Additional Director in the category of Non-Executive Independent Director, effective August 15, 2026. The term of Ms. Nilima Ramrao Shinde as an Independent Director concluded on October 31, 2026.
Mr. Sun Yajie was redesignated from Whole-Time Director to Non-Executive Non-Independent Director, effective August 14, 2026, and also ceased to be Chief Technology Officer. Mr. He Liuwei was appointed as Chief Technology Officer (CTO) effective August 15, 2026, and Mr. Saravanan Balasundaram was appointed as Chief Marketing Officer (CMO) effective August 15, 2026.
What to do with a filing like this
Kingfa Science & Technology (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kingfa Science & Technology (India) Limited. Read the original for the full detail.